Key result
Intramuscular glycopyrrolate reduced the incidence of hypotension compared to normal saline in elderly patients undergoing subarachnoid block.
Why the study?
Hypotension is a frequent complication of spinal anaesthesia, particularly in the elderly, and glycopyrrolate was evaluated to see if it prevents post-subarachnoid block hypotension.
Does intramuscular glycopyrrolate prevent hypotension after subarachnoid block in elderly patients?
RCT (n=44)
Double-blind
randomized
Does intramuscular glycopyrrolate prevent hypotension after subarachnoid block in elderly patients?
Intramuscular glycopyrrolate administered 15 minutes before subarachnoid block significantly reduces the incidence of hypotension and the need for rescue vasopressors in elderly patients.
Answers are grounded in this paper and cite their sources.
May warrant preemptive intramuscular glycopyrrolate in elderly subarachnoid block patients; confirms reduced hypotension and vasopressor needs in this RCT.
Background Hypotension is one of the most frequent complications during spinal anaesthesia. It is more common in elderly with a reported incidence of 65–75%. While keeping in mind that the hypotension induced by subarachnoid block is related to sympathetic blockade accompanied with bradycardia, the administration of glycopyrrolate could affect hemodynamic during spinal anaesthesia. Thus, we aimed at evaluating the role of intramuscular glycopyrrolate in preventing hypotension after subarachnoid block in elderly patients. Patients and methods It’s a randomized double blind study. Forty four patients (60–80 years of age, ASA I and II) posted for lower abdominal surgery or lower limb surgery were given subarachnoid block using standard anaesthesia technique. They were administered either 1 ml of normal saline (group N) or 0.2 mg glycopyrrolate (group G) intramuscularly 15 minutes before subarachnoid block. Parameters like blood pressure and heart rate (at preset time intervals), total requirement of ephedrine, time to first rescue vasopressor i.e. ephedrine, incidence of nausea and vomiting and requirement of Ondansetron, incidence of bradycardia and requirement of atropine, presence of dry mouth etc was recorded. Results Eleven of 22 (50%) patients in group N experienced hypotension compared with two of 22(9.09%) patients in group G (difference=40.91%; P =0.001). The mean ephedrine requirement in group G is 0.45±1.47 mg while, in group N is 3.63±4.41 mg ( P =0.001). There was no case of bradycardia reported in group G although, two out of 22 patients (9.09%) in group N reported bradycardia ( P =0.55). There is no incidence of nausea and vomiting in group G while, 3 patients in group N complained about nausea and vomiting ( P =0.03). Conclusion The intramuscular administration of 0.2 mg glycopyrrolate in elderly patients undergoing subarachnoid block significantly reduces the incidence and degree of hypotension; and reduces the total consumption of rescue vasopressor without any clinically significant side effect.
No takes yet. Share an insight, caveat, or question.
Gargava et al. (2021) conducted an RCT in Hypotension after subarachnoid block (n=44). Glycopyrrolate vs. 1 ml of normal saline was evaluated on incidence of hypotension (difference 40.91%, p=0.001). Intramuscular glycopyrrolate reduced the incidence of hypotension compared to normal saline in elderly patients undergoing subarachnoid block.
Synapse has enriched 10 related papers. Consider them for comparative context: